Key result
EP testing optimizes amiodarone therapy for recurrent life-threatening ventricular tachyarrhythmias.
Why the study?
To review the value of electrophysiologic study in patient selection and in guiding amiodarone therapy for recurrent, life-threatening ventricular tachyarrhythmias.
Does electrophysiologic testing optimize the use of amiodarone in patients with recurrent, life-threatening ventricular tachyarrhythmias?
Does electrophysiologic testing optimize the use of amiodarone in patients with recurrent, life-threatening ventricular tachyarrhythmias?
Electrophysiologic testing is valuable for patient selection and guiding amiodarone therapy in patients with life-threatening ventricular tachyarrhythmias.
Answers are grounded in this paper and cite their sources.
EP testing should guide amiodarone selection and monitoring in VT; confirms noninducibility predicts lower recurrence and improved survival.
S okoloff NM, and H orowitz LN: Amiodarone: the role of electrophysiological testing . This report reviews the value of electrophysiologic study in appropriate patient selection and in the assessment and guidance of amiodarone therapy. The implications of noninducibility, changes in induced cycle length, aggressiveness of stimulation, relation to clinical outcome in terms of sustained arrhythmia recurrence and in terms of survival, pharmacokinetics, and nonclinical induced arrhythmias are discussed. The role in which data obtained noninvasively contribute to patient assessment and management, both in combination with data obtained from programmed electrical stimulation and when used independently, is analyzed. The rationale for complete electrophysiologic testing in most all patients to optimize use of this potent and potentially high toxic antiarrhythmic agent for treatment of recurrent, life‐threatening ventricular tachyarrhythmias is summarized .
No takes yet. Share an insight, caveat, or question.
Sokoloff et al. (1986) conducted a review in recurrent, life-threatening ventricular tachyarrhythmias. Electrophysiological testing was evaluated. Electrophysiologic testing is recommended to optimize the use of amiodarone for the treatment of recurrent, life-threatening ventricular tachyarrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: